The way towards tailored treatment for metastatic renal cancer patients in the
omics
era: are we getting a "transcriptomic compass"?
Ann Transl Med
.
2019 Sep;7(Suppl 6):S190.
doi: 10.21037/atm.2019.07.37.
Authors
Melissa Bersanelli
1
2
,
Alessio Cortellini
3
4
,
Sebastiano Buti
1
Affiliations
1
Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
2
Department of Medicine and Surgery, University of Parma, Parma, Italy.
3
Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.
4
Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
PMID:
31656769
PMCID:
PMC6789366
DOI:
10.21037/atm.2019.07.37
No abstract available
Publication types
Editorial
Comment